KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

ACM Research (ACMR) Operating Expenses (2016 - 2025)

ACM Research (ACMR) has disclosed Operating Expenses for 10 consecutive years, with $76.9 million as the latest value for Q4 2025.

  • On a quarterly basis, Operating Expenses rose 15.03% to $76.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $290.6 million, a 20.82% increase, with the full-year FY2025 number at $290.6 million, up 20.82% from a year prior.
  • Operating Expenses was $76.9 million for Q4 2025 at ACM Research, down from $84.2 million in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $84.2 million in Q3 2025 to a low of $14.6 million in Q1 2021.
  • A 5-year average of $45.6 million and a median of $46.0 million in 2023 define the central range for Operating Expenses.
  • Peak YoY movement for Operating Expenses: soared 98.64% in 2022, then increased 5.35% in 2025.
  • ACM Research's Operating Expenses stood at $26.3 million in 2021, then soared by 41.09% to $37.1 million in 2022, then soared by 50.0% to $55.7 million in 2023, then increased by 19.97% to $66.8 million in 2024, then increased by 15.03% to $76.9 million in 2025.
  • Per Business Quant, the three most recent readings for ACMR's Operating Expenses are $76.9 million (Q4 2025), $84.2 million (Q3 2025), and $72.8 million (Q2 2025).